Inositol is a second messenger precursor that is effective in depression an
d obsessive-compulsive disorder via a mechanism different from serotonin re
uptake inhibitors. However, controlled trials of inositol combined with ser
otonin reuptake inhibitors in depression or in reuptake inhibitor resistant
depressed patients, or in partially responsive obsessive-compulsive patien
ts, did not reveal added benefit. This is comparable to results with combin
ations of other antidepressant treatments, such as tricyclics plus monoamin
e oxidase inhibitors. Copyright (C) 2001 John Wiley & Sons, Ltd.